Post

New research · Ophthalmology
Ocular oncology and pathology · 1d
Cohort studyOcular oncology and pathology · 2026

Unilateral Glaucoma as a Clinical Indicator of Iris and Ciliary Body Melanoma.

Gillian A Folk, Naren Ramesh, Nathan L Scott
Read paper
OphthalmologyCohort study

Glaucoma is much more common in eyes with iris or ciliary body melanoma than nevus.

Unilateral Glaucoma as a Clinical Indicator of Iris and Ciliary Body Melanoma.

Gillian A Folk … Nathan L Scott
Ocular oncology and pathology · 2026
Background

Iris and ciliary body melanomas are rare but potentially life-threatening tumors that are difficult to distinguish from benign nevi.

Methods

With iris or ciliary body melanoma or nevus were identified by International Classification of Diseases, Tenth Revision (ICD-10) diagnostic codes.

n = 17,978 patients
Results

eyes with melanoma were far more likely to also have glaucoma than eyes with nevus

OR by subgroup · 95% CI
null = 1
melanoma cohort than nevus cohort
10.10
patients aged 20-39 years
14.20
More results

Among patients with glaucoma, surgery was required more frequently in the melanoma cohort (18.9%) than nevus cohort (15.0%).

“
Conclusion · 1 of 3

Unilateral glaucoma is significantly more common in eyes with iris and ciliary body melanoma than in those with iris and ciliary body nevus in this claims-based cohort, and melanoma patients are more likely to require surgical management.

Conclusion · 2 of 3

Unilateral glaucoma may serve as an important early clinical indicator of melanoma, although further clinical correlation is necessary.

Conclusion · 3 of 3

Incorporating glaucoma status into diagnostic criteria could improve recognition, prompt referral and biopsy, and reduce delays in treatment.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving